Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bailing Yuxiu Pharmaceutical is a specialized subsidiary of Huadong Medicine, focused on the manufacturing and commercialization of the Bailing product line. The company's flagship product, Bailing Capsule, is a fermented Cordyceps sinensis powder preparation widely used in China for treating chronic kidney disease and respiratory ailments. By utilizing advanced large-scale fermentation technology, Bailing Yuxiu bridges the gap between traditional Chinese medicine and modern biotechnology. The company operates as a core component of Huadong Medicine's pharmaceutical industrial chain, maintaining high GMP standards for its production facilities. Its business model centers on the lifecycle management and market expansion of its proprietary fungal-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bailing Yuxiu Pharmaceutical.